Bumper Offer - Urjas oil Just @ Rs. 1 X
Vepan 125 Tablet, a prescription drug, is manufactured in various forms such as Tablet. Primarily, it is used for the treatment of Bacterial Infections, Tonsillitis, Throat Infection. Secondary and off-label uses of Vepan 125 Tablet have also been mentioned below.
The optimal dosage of Vepan 125 Tablet is largely dependent on the individual's body weight, medical history, gender and age. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Detailed information has been provided in the dosage section.
Apart from the aforementioned side effects, Vepan 125 Tablet can also lead to other problems, which have been listed below. Normally, these side effects of Vepan 125 Tablet are not long lasting and go away when the treatment is finished. Please speak with your doctor if these side effects worsen or persist for a longer duration.
It is also important to note that Vepan 125 Tablet has a Safe effect for pregnant women and Safe effect on lactating mothers. It is important to know if Vepan 125 Tablet has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Vepan 125 Tablet related warnings section.
Other contraindications of Vepan 125 Tablet have been discussed in the sections ahead.
Besides this, Vepan 125 Tablet may also have severe interaction with some medicines. See below for a complete list.
In addition to these precautions, you may also note that Vepan 125 Tablet is not safe while driving, and is is not addictive in nature.
Vepan 125 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
| 2 - 12 years (Child) |
|
| Infant (1 month to 2 years) |
|
Based on research, the following side effects have been observed when Vepan 125 Tablet is used -
Severe
Mild
Is the use of Vepan 125 Tablet safe for pregnant women?
Pregnant women can take Vepan safely.
Is the use of Vepan 125 Tablet safe during breastfeeding?
Vepan is completely safe for breastfeeding women.
What is the effect of Vepan 125 Tablet on the Kidneys?
Vepan rarely harms the kidneys.
What is the effect of Vepan 125 Tablet on the Liver?
Vepan is not harmful for the liver.
What is the effect of Vepan 125 Tablet on the Heart?
There are no any side effects of Vepan for the heart.
Vepan 125 Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Vepan 125 Tablet unless your doctor advises you to do so -
Is this Vepan 125 Tablet habit forming or addictive?
No, you will not get addicted to Vepan 125 Tablet.
Is it safe to drive or operate heavy machinery when consuming?
You may feel sleepy or tired after taking Vepan 125 Tablet. So it is best to avoid driving.
Is it safe?
Yes, but take Vepan 125 Tablet only as per medical advice.
Is it able to treat mental disorders?
Vepan 125 Tablet is unable to treat or cure mental disorders.
Interaction between Food and Vepan 125 Tablet
You can take Vepan 125 Tablet with food.
Interaction between Alcohol and Vepan 125 Tablet
You may consume alcohol while taking Vepan 125 Tablet. But caution is still important.
This medicine data has been created by -
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 299-300
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 726
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Duricef® (cefadroxil monohydrate)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 299-300
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 726
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Duricef® (cefadroxil monohydrate)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 299-300
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 726
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Duricef® (cefadroxil monohydrate)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 299-300
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 726
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Duricef® (cefadroxil monohydrate)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 299-300
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 726
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Duricef® (cefadroxil monohydrate)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 299-300
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 726
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Duricef® (cefadroxil monohydrate)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 299-300
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 726
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Duricef® (cefadroxil monohydrate)